Besides a direct impact on IP3R/Bcl-XL complexes, ABT-737 has also been proposed to modulate the sensitivity of cancer cells to chemotherapy via a mechanism that involves remodeling of ER–mitochondrial contact sites (82). This evidence concerns the gene ITPR1 and cancer.